PDSB PDS Biotechnology Corporation

6.19
+0.17  (+3%)
Previous Close 6.02
Open 6.15
Price To Book 1.31
Market Cap 32,048,645
Shares 5,177,487
Volume 10,442
Short Ratio
Av. Daily Volume 186,337

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 trial planned for 4Q 2019.
PDS0101
Human papilloma virus (HPV)
Phase 2 planned for 4Q 2019.
PDS0101 and Keytruda
Head and neck cancer